SCHEMBL9023936

SCHEMBL9023936

O=c1c2ccccc2n2nc(CBr)c3ccc(Br)c1c32

nearest known ligand 0.34

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 7/20 0.34
▸ NQO1 P15559 6/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ G6PD P11413 1/20 0.32
▸ PARP1 P09874 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ MAPT P10636 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ P2RX4 Q99571 1/20 0.31
▸ CYP1B1 Q16678 3/20 0.31
▸ GLA P06280 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9023550 0.86 G6PD (0.46) NQO2NQO1ALDH1A1G6PDPARP1
SCHEMBL9023982 0.83 MAPT (0.36) G6PDMAPTHTT
SCHEMBL9024240 0.83 KDM1A (0.38) NQO2NQO1PARP1P2RX4
SCHEMBL9025088 0.82 ALDH1A1 (0.40) NQO2NQO1ALDH1A1PARP1CYP1A2
SCHEMBL9023793 0.81 ALDH1A1 (0.41) NQO2NQO1ALDH1A1PARP1CYP1A2
SCHEMBL9024132 0.80 ALDH1A1 (0.33) ALDH1A1PARP1MAPTHTTGLA
SCHEMBL9737446 0.77 NQO1 (0.33) NQO2NQO1
SCHEMBL9024950 0.77 AR (0.40) NQO2NQO1PARP1MAPTHTT
SCHEMBL9024099 0.75 NQO1 (0.32) NQO2NQO1
SCHEMBL9024559 0.73 MAPT (0.39) G6PDMAPTHTTCYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0347749-B1 Pyrazoloacridone derivatives with anti-tumoral activity KYOWA HAKKO KOGYO KK (JP) 1996-04-24 — — EP disclosed
US-5079358-A Humans; leukemia KYOWA HAKKO KOGYO CO., LTD. (JP) 1992-01-07 — — US disclosed
EP-0347749-A2 Pyrazoloacridone derivatives with anti-tumoral activity KYOWA HAKKO KOGYO CO., LTD. (JP) 1989-12-27 — — EP disclosed
Send feedback